Liver transplantation in the United States: Current problems and future goals

Italian Journal of Gastroenterology

Volumn 28, Issue 3, 1996, Pages 169-175

  Van Thiel, D H ^a   Colantoni, A ^a   De Maria, N ^a   Fagiuoli, S ^b   Gasbarrini, A ^c   Hassanein, T ^d  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d University of California   (United States)

Author keywords

Cadaveric organs; Liver allografts; Liver transplantation; Living related transplantation

Indexed keywords

ARTICLE; CADAVER DONOR; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; SURVIVAL; UNITED STATES;

ADULT; CADAVER; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HUMANS; INFANT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; UNITED STATES; WAITING LISTS;

EID: 0029938518     PISSN: 03920623     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Annual Report of the U.S: Scientific Registry of Transplant Recipient and the Organ Procurement and Tran-splantation Network. U.S. Department of Health and Services. Int Book number 1-886651-10-8, 97.
2. Shaw BW Jr, Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected patient variable and operative blood loss on 6 months survival following liver transplantation. Sem Liver Dis 1985; 5: 385-93.
3. Belle SH, Beringer KC, Detre KM. Liver Transplantation in the United States: Results from the National Pin-UNOS Liver Transplant Registry. In: Terasaki PI, Cecka JM (Eds): Clinical Transplants 1994, Los Angeles, UCLA Tissue Typing Lab, 1995: 19-35.
4. Broelsch CE, Whittington PF, Emond JC, Heffron TG, Thistlethwaite JR, Steven L, Piper J, Whitington SH, Lichtor JC. Liver transplantation in children from living related donors. Ann Surg 1991; 214: 428-39.
5. Kahn D, Gavaler JS, Makowka L, Starzl TE, Van Thiel DH. The gender of the donor influences the outcome after orthotopic liver transplantation in adults. Dig Dis Sci 1993; 38: 485-8.
6. Miller C. The older patient: what are the limits? AASLD course: The liver transplant evaluation: linking risk factors and outcome. Chicago, November 3, 1995: 15-22.
7. Trevisani F, Colantoni A, Caraceni P, Van Thiel DH. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol 1996; 24: 114-21.
8. Emond JE. Evaluation of the living related transplant: donor and recipients. AASLD course: The liver transplant evaluation: linking risk factors and outcome. Chicago, November 3, 1995: 103-16.
9. Henderson JM. The patient with variceal bleeding. AASLD course: The liver transplant evaluation: linking risk factors and outcome. Chicago, November 3, 1995: 45-60.
10. Samuel D, Muller R, Alexander G. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842-7.
11. Van Thiel DH, Wright HI, Fagiuoli S. Liver transplantation for hepatitis B virus associated cirrhosis: a progress report. Hepatology 1994; 20: 20S-23S.
12. Bizollon G, Ducerf L, Sciarrino E, et al. Ribavirin and interferon treatment for hepatitis C recurrence following orthotopic liver transplantation. J Hepatol 1994; 21: S58.